UK: New UK Pharmaceutical Packaging Warnings: Lucy In The Sky With Directions For Marketing Authorisation Holders

This client alert looks at the impact of a new drug driving offence in the UK which will come into effect during 2014 as part of The Crime and Courts Act 2013 (the "CCA 2013"). It is relevant for UK Marketing Authorisation Holders ("MAHs") with medicines containing specified controlled drugs.

Executive summary

The CCA 2013 introduces a new offence for driving under the influence of drugs, which will become enforceable later this year. This new offence is primarily intended to remedy the failings of section 4 of the Road Traffic Act 1988 (the "RTA 1988"). The RTA 1988 made it a criminal offence to drive under the influence of a controlled drug, but this was found to be difficult to prove. The new offence under the CCA 2013 addresses this issue and takes into account the fact that some specified controlled drugs may be taken by drivers legitimately.

In light of this, the Medicines and Healthcare Products Regulatory Agency (the "MHRA") has requested that all MAHs with medicines using specified controlled drugs update the Summary of Product Characteristic (the "SmPC"), the patient information leaflet and the product labelling of their medicines to include new warnings to notify prescribers and patients of the change. The MHRA has provided MAHs with wording for this purpose and set a deadline of 28 February for MAHs to provide their Type 1A notifications to the MHRA.


On 10 December 2013, the MHRA wrote a letter to MAHs informing them of new compliance requirements for the packaging and labelling of their medicines following a new drug driving offence introduced as part of the CCA 2013. The MHRA stated that the Department of Transport has set a date of September 2014 as the anticipated date for the legislation to take effect, following a debate in Parliament due in early 2014, during which the regulations are expected to be finalised and after which the offence will become enforceable.

The offence

Before the CCA 2013 was introduced, regulations relating to drugs and driving were considered under the Misuse of Drugs Act 1971 (the "MDA 1971") and the RTA 1988.

The MDA 1971 prohibited the production, import, export, possession and supply of "controlled drugs" (a list of which can be found here), but stated that it was not a criminal offence to have a controlled drug in your body. Section 4 of the RTA 1988, on the other hand, made it a criminal offence to drive a vehicle when under the influence of drink or drugs. The difficulties involved in proving driving impairment due to drugs meant that section 4 of the RTA 1988 was not often used in drug driving cases.

The offence under the CCA 2013 is similarly aimed at dangerous drivers who use drugs recreationally and drive under their influence. However, unlike section 4 of the RTA 1988, the offence under the CCA 2013 acknowledges that many controlled drugs are often used legitimately and that it can be difficult to distinguish therapeutic use from recreational use.

With this in mind, the offence under the CCA 2013 provides a statutory defence which states that it is a defence for a person to show that: (i) the specified controlled drug had been prescribed or supplied to them for medical or dental purposes; (ii) they took the drug in accordance with any directions given by the person who prescribed or supplied the drug, and with any accompanying instructions (so far as consistent with any such directions) given by the manufacturer or distributor of the drug; and (iii) their possession of the drug immediately before taking it was not unlawful under the MDA 1971.

Furthermore, the new offence provides that this defence is not available if the individual's actions were: (i) contrary to any advice, given by the person by whom the drug was prescribed or supplied, about the amount of time that should elapse between taking the drug and driving a motor vehicle; or (ii) contrary to any accompanying instructions about that matter (so far as consistent with any such advice) given by the manufacturer or distributor of the drug.

Directions for MAHs

The letter from the MHRA to MAHs states that MAHs need to provide both health care professionals and patients with additional information where their medicines are considered controlled drugs under the new offence. The MHRA specifically reminds MAHs that the offence also includes medicines that are metabolised into a controlled drug.

The MHRA has requested that MAHs update the SmPC and patient information leaflet of their relevant medicines with new warnings. This includes updating packaging to draw patients' attention to the new information with the addition of a "new warning" flash to the front of packets. The MHRA has provided MAHs with specific wording for these warnings, which can be found in the letter here in Annexes I and II respectively.

Furthermore, the MHRA has stated that the new warning flash on the front of packaging should not be removed until after September 2015. Before removing the warning flash, MAHs are required to complete a Better Recognition of Medicines Initiative notification (BROMI) informing the MHRA of the removal.


The MHRA has stated that the revised information will need to be included in labels and leaflets by September 2014. Variations should be sent to the MHRA as Type 1A notifications, stating the reason as "Addition of driving warnings in line with MHRA directions".

MAHs are reminded that Type 1A notifications are variation applications which are accompanied by dedications and statements from the MAH and do not include information which requires assessment by the MHRA. There is also no fee for this type of submission.

Most importantly, MAHs must keep in mind that there is a 14 day acknowledgment period for a valid application using a Type 1A notification and the MAH should wait for confirmation from the MHRA before making any changes. This is especially pertinent as all variations are to be submitted to the MHRA by 28 February. MAHs should send in their Type 1A notifications as soon as possible for any products which are considered under the CCA 2013 offence.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.